製品の概要

  • 製品名Anti-NUFIP1 antibody
    NUFIP1 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to NUFIP1
  • アプリケーション適用あり: IPmore details
    適用なし: WB
  • 種交差性
    交差種: Human
    交差が予測される動物種: Chimpanzee
  • 免疫原

    Synthetic peptide, corresponding to a region within amino acids 445-495 of Human NUFIP1 (NP_036477.2)

  • ポジティブ・コントロール
    • HeLa cell lysates.

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab113206 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
IP Use at 2-10 µg/mg of lysate.
  • 追加情報Is unsuitable for WB.
  • ターゲット情報

    • 関連性NUFIP1 contains 1 C2H2- type zinc finger and binds RNA. It interacts with FMR1. NUFIP1 may be associated with preinitiation complexes, open transcription complexes, and elongation complexes. It may facilitate ATP-dependent dissociation of hyperphosphorylated pol II from open transcription complexes.
    • 細胞内局在Nuclear
    • 参照データベース
    • 別名
      • bA540M5.1 antibody
      • Nuclear FMRP interacting protein 1 antibody
      • Nuclear fragile X mental retardation interacting protein 1 antibody
      • nuclear fragile X mental retardation protein interacting protein 1 antibody
      • NUFIP antibody
      see all

    Anti-NUFIP1 antibody 画像

    • Detection of NUFIP1 by Western Blot of Immunprecipitate.
      Lane 1: ab113206 at 0.4µg/ml staining NUFIP1 in HeLa whole cell lysate immunoprecipitated using ab113206 at 6µg/mg lysate (1 mg/IP; 20% of IP loaded/lane).
      Lane 2: Control IgG
      Detection: Chemiluminescence with exposure time of 3 minutes.

    Anti-NUFIP1 antibody (ab113206) 使用論文

    ab113206 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab113206.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"